Novo Nordisk A/S Chief Executive Officer Mike Doustdar talks about the company's performance as its popular Wegovy weight-loss pill disappointed investors with sales that failed to live up to the hype. "We are not right now discussing further discounts," Doustdar tells Bloomberg's Francine Lacqua.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/videos/2026-08-05/novo-not-discussing-further-pill-discounts-ceo-says-video)